Low-dose Tissue Plasminogen Activator is as Effective as Standard Tissue Plasminogen Activator Administration for the Treatment of Acute Ischemic Stroke

Publisher： Bentham Science Publishers

E-ISSN： 1875-5739|11|1|62-67

ISSN： 1567-2026

Source： Current Neurovascular Research, Vol.11, Iss.1, 2014-01, pp. : 62-67

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Free Radical Scavenger Edaravone Administration Protects against Tissue Plasminogen Activator Induced Oxidative Stress and Blood Brain Barrier Damage

By  

Current Neurovascular Research, Vol. 7, Iss. 4, 2010-11 ,pp. : 319-329

Bentham Science Publishers

Access to resources Recommend Favorite

Tissue Plasminogen Activator Prevents Restoration of Tight Junction Proteins Through Upregulation of Angiopoietin-2

By  

Current Neurovascular Research, Vol. 10, Iss. 1, 2013-02 ,pp. : 39-48

Bentham Science Publishers

Access to resources Recommend Favorite

Serum Bilirubin after Acute Ischemic Stroke is Associated with Stroke Severity

By  

Current Neurovascular Research, Vol. 9, Iss. 2, 2012-05 ,pp. : 128-132

Bentham Science Publishers

Access to resources Recommend Favorite

Oxidative Stress in Post-Acute Ischemic Stroke Patients after Intensive Neurorehabilitation

By  

Current Neurovascular Research, Vol. 9, Iss. 4, 2012-11 ,pp. : 266-273

Bentham Science Publishers

Access to resources Recommend Favorite

Evidence of Redox Unbalance in Post-Acute Ischemic Stroke Patients

By  

Current Neurovascular Research, Vol. 9, Iss. 2, 2012-05 ,pp. : 85-90

Bentham Science Publishers

Access to resources Recommend Favorite